A number of good-quality prospective studies have evaluated the effectiveness of different psychosocial and psychological treatment programs for borderline and other severe personality disorders (PDs) [1] [2] [3] . The results have shown that these newly developed and refined approaches have substantially improved the prognosis of personality-disordered patients, and have contributed to reversing the therapeutic pessimism concerning the treatability of these conditions [4] . However, we found only a handful of reports that have attempted to identify patients' clinical characteristics predictive of treatment outcome [5] [6] [7] .
A number of good-quality prospective studies have evaluated the effectiveness of different psychosocial and psychological treatment programs for borderline and other severe personality disorders (PDs) [1] [2] [3] . The results have shown that these newly developed and refined approaches have substantially improved the prognosis of personality-disordered patients, and have contributed to reversing the therapeutic pessimism concerning the treatability of these conditions [4] . However, we found only a handful of reports that have attempted to identify patients' clinical characteristics predictive of treatment outcome [5] [6] [7] .
At the Cassel Hospital, Richmond, UK, where the current study has taken place, the type of approach developed is mostly targeted at patients who present with cluster B disorders. The residential and follow-on outpatient settings at the Cassel Hospital offer specific medium and long-term psychosocial treatments to tackle the core symptoms and structural imbalances presented by patients with cluster B disorders that have been unresponsive to general psychiatric interventions. However, since we do not yet know which patients within the cluster B spectrum are more responsive to this type of psychosocial approach and which clinical characteristics may be prognostic of outcome, we selected a relatively homogeneous group of patients with a standardized diagnosis of three cluster B PDs (borderline, histrionic and narcissis-tic), and we attempted to locate the presence of significant predictive factors that influenced positive and negative medium-term outcome. Because of the high comorbidity of diagnosis in the sample, we also set out to evaluate whether specific combinations of diagnostic categories within Axis I and Axis II were significantly associated with outcome 24 months after intake. In addition, we explored predictors of outcome specific to each treatment in order to refine clinical recommendations for selection of specific programs.
Method

Participants
All patients consecutively admitted to the Cassel Hospital for psychosocial treatment (n = 137) over a 4-year period who met inclusion criteria (age between 19-55 years, IQ 1 80 and presence of at least one PD)) were considered for the study. Exclusion criteria were diagnosis of schizophrenia, psychoactive substance addiction and evidence of organic brain disorder. All patients were screened using the SCID-I and SCID-II [8] for the presence of Axis I and Axis II diagnosis. After considering the number of patients that did not meet the criteria (3%), consent refusal (11%) and study dropouts (15%), 94 patients were followed up through to the 24-month assessment point [9] . Seventy-three subjects met the DSM-III-R criteria for at least one cluster B PD, and these constituted the study sample for this investigation. The majority had a primary diagnosis of borderline PD (n = 54, 74%), while the remaining met the criteria for narcissistic (n = 10, 14%) and histrionic (n = 9, 12%) PD.
Treatment Setting
The Cassel Hospital is a tertiary psychiatric facility that offers psychotherapeutic and psychosocial rehabilitation for patients suffering from PDs that have been unresponsive to a range of general psychiatric and outpatient psychotherapeutic interventions. Patients referred from outside the Greater London area are admitted to a long-term inpatient program entailing 12 months residential treatment within the hospital therapeutic community milieu with no planned follow-on treatment. Patients within Greater London are allocated to a step-down program consisting of a period of 6 months as inpatient followed by 2 years of psychotherapy and outreach nursing in the patient's own community.
The inpatient program consists of a combination of sociotherapy, with emphasis on rehabilitation and psychoeducation, and psychoanalytically oriented psychotherapy. In the outreach stage of the step-down program, patients attend twice weekly smallgroup analytically oriented psychotherapy, once weekly half-day meetings with the outreach nurse for community support and rehabilitation, and regular reviews with the senior psychiatrist in charge of the program [10] .
Predictor Variables and Outcome Measures
Comprehensive sociodemographic and background premorbid variables were collected at intake using the rater-based version of the Cassel Baseline Questionnaire [11] . A structured interview, modeled on the Suicide and Self-Harm Inventory [2] was applied at intake, 12 months and 24 months to obtain details of self-harm episodes, number and length of psychiatric inpatient episodes and of psychiatric outpatient attendance over the year prior to the assessment. Each variable was operationally defined.
Outcome was assessed in three main areas of functioning: severity of symptom presentation, social adjustment and global assessment of functioning. The measures were applied at intake, 6, 12 and 24 months after intake.
The Symptom Checklist-90-R (SCL-90-R) [12] is a five-point self-report clinical rating scale. The SCL-90-R general severity index (GSI) was the total score used in the study to report changes in symptomatic distress.
The interviewer-based version of the Social Adjustment Scale (SAS) [13] rates adjustment in the areas of work, family of origin, marriage, sexuality and social leisure on a five-point scale. A total social adjustment score is computed from the raw scores.
The Global Assessment Scale (GAS) [14] is an anchored rating scale (0-100) used for the evaluation of global outcome in accordance with patient's level of functioning assessed during the 4 weeks preceding the assessment.
These measures were applied by a team of research psychologists and psychiatrists, independent of the clinical teams, who were trained to reliability criteria on all measures.
Definition of Improvement and Statistical Analysis
Subjects were defined as overall improved if they met the Jacobson and Truax criteria [15] for clinically significant change in at least one of the three main outcome measures by 24-month follow-up evaluation. We have chosen this criterion for overall improvement because it gives a relatively even split between improvers and nonimprovers and, given a high correlation between the three outcome variables (reported below), clinically significant change in one will generally reflect very substantial change in the other two.
Using a categorical (as opposed to a dimensional) approach to outcome may reduce statistical power and increase the risk of type II errors. In the present analysis, we were concerned to separate patients who showed some significant benefit from the treatment and differentiate them from those who did not, while dimensional measures might be overly weighted towards identifying predictors associated with changes at the extreme ends of distributions, which is not of such great concern to most clinicians. Thus, while our approach may miss some important predictors that can identify an individual in an outlying group, it allows the distinction between those who show clinically significant changes versus those who do not.
Data were analyzed using the Statistical Package for the Social Sciences (SPSS, version 12). Predictor variables were entered into a stepwise logistic regression analysis with improvement status as the dependent variable. In order to facilitate the generation of an odds ratio in the predictor analysis, we computed standardized values for continuous and Likert scale variables (GSI, GAS, age and treatment length). Two separate cluster analyses were also carried out on the SCID-derived diagnosis found in the sample.
We used Cohen's h to calculate the magnitude of the difference (effect sizes) between two proportions (rates of improvement) according to the formula: 2 ؒ (arcsin Ί P 1 ) -2 ؒ (arcsin Ί P 2 ) [16] .
Results
Demographic and Clinical Features
The average age of the sample was 30 years (SD = 6.3), 75% were females, single and achieved college educational status. However, 9 out of 10 subjects were unemployed and on social welfare benefits at the time of entering treatment. Over 50% experienced early environmental traumas in the form of loss of primary caregivers, sexual and physical abuse, alone or in combination. Concerning previous psychiatric utilization, half of the sample had at least one psychiatric admission in the year before the intake assessment and 90% were in one or more types of outpatient psychiatric treatment over the same period. They met, on average, criteria for 4 SCID-II (prevalence) psychiatric syndromes and 3.5 PDs. The most common Axis I conditions were major depression (69%), bulimia (33%), panic disorder (31%), sociophobic disorder (30%) and obsessive-compulsive disorder (29%). Axis II comorbidity with cluster A and C disorders included paranoid (51%), schizotypal (18%), avoidant (49%), dependent (34%), self-defeating (49%) and passive-aggressive (21%) PDs.
Summary of Outcome
Using the formulas provided by Jacobson and Truax 1 [15] , which yielded a cutoff point for SCL-90-R GSI (cutoff = 1.01), SAS (cutoff = 2.07) and GAS (cutoff = 59.63), allowed us to define the boundary of 'clinically relevant change' for each computed outcome variable at 24-month follow-up in the cluster B sample. The correlation between the three outcome variables was highly significant (GSI-SAS: Spearman's rho = 0.58, p ! 0.0001; GSI-GAS: Spearman's rho = 0.58, p ! 0.001; SAS-GAS: Spearman's rho = 0.72, p ! 0.0001).
At the 24-month assessment point, 27 (37%), 32 (43.8%) and 32 (43.8%) were improved to the criteria for GSI, SAS and GAS, respectively. Forty-one (56.2%) patients showed overall improvement (improvement in at least one out of three measures). Rates of improvement were significantly higher when cluster B patients had been treated in the step-down model compared with patients treated in the long-term inpatient model for GSI ( 2 = 13.02, d.f. = 1, p ! 0.001) and SAS ( 2 = 5.81, d.f. = 1, p ! 0.02), while differences in GAS ( 2 = 3.75, d.f. = 1, p = 0.053) almost reached significance. A significant difference between the two treatment groups was also found in overall improvement (step-down model: n = 28, 66.7%; long-term inpatient model: n = 18, 40.9%, 2 = 5.73, d.f. = 1, p ! 0.02), a difference in favor of the step-down model already present at the 12-month follow-up assessment ( 2 = 5.90, d.f. = 1, p ! 0.02). These results for cluster B patients confirmed the previously reported findings for the larger sample of PDs [9, 11] .
Predictor Analysis
Forty-one demographic, diagnostic and clinical variables were tested for their association with outcome at 24-month follow-up using 2 test and one-way ANOVA. These variables included: age, gender, race, marital status, educational attainment, occupational and employment status, level of state benefits, quantity of work, accommodation status, presence of organic pathology, early loss, maltreatment, sexual abuse, trouble with the law, age at onset of symptoms, substance abuse, self-mutilation, attempted suicide, previous psychiatric hospitalization, length of current problems, number and length of previous psychiatric outpatient treatment, type and length of time on psychotropic medication, severity of symptoms, length of treatment, levels of social adjustment, global functioning and main Axis I and II diagnosis.
We found that age, self-mutilation, avoidant PD, dependent PD, schizotypal PD, average number of PD diagnosis, length in treatment, symptom severity (GSI) and global assessment of functioning (GAS) intake scores were significantly associated with improvement status at 24-month follow-up ( table 1 ) .
These variables were entered into a stepwise logistic regression analysis with improvement status as the dependent variable; the sequence of variable entry into the SPSS stepwise procedure was determined by the level of statistical significance. It was revealed that the model including self-mutilation the year prior to intake, avoidant PD, intake GAS scores, age at intake and length of treatment was predictive of improvement at 24 months ( 2 = 31.60, d.f. = 5, p ! 0.001).
Cluster B patients with no previous self-mutilation (B = -1.82, SE = 0.64, d.f. = 1, p = 0.01), no comorbid avoidant PD (B = -1.30, SE = 0.61, d.f. = 1, p = 0.03), with 1 We used criterion (c) for GSI and SAS: the level of functioning after therapy places subjects closer to the mean of the functional population than it does to the mean of the dysfunctional population, according to the formula: cut-off = (SD0 ؒ M1 + SD1 ؒ M0)/(SD0 + SD1), where SD0 is the standard deviation of the functional population, M1 is the pretest mean of the dysfunctional population, SD1 is the standard deviation of the dysfunctional population and M0 is the mean of the normal population. Since no normative data were available for GAS, we used criterion (a): the level of functioning after therapy falls outside the range of the dysfunctional population, i.e. two standard deviations beyond the pretreatment mean of that population in the direction of functionality [M2 6 M1(-or +)2SD1]. Data are expressed as either mean 8 SD or n (%). ( table 2 ) . Absence of self-mutilation and comorbid avoidant PD improved sixfold(95% CI 21.74-1.74) and fourfold (95% CI 12.05-1.13) the chances to achieve positive outcome, respectively. Six years (1 SD) below the mean age of 30 years, 31 weeks (1 SD) more treatment from the mean of 53 weeks and 6.5 points (1 SD) above the GAS mean score of 46.5 doubled the chances of improvement 2 years after treatment ( table 2 ) .
Improvement and Self-Mutilation
Although self-mutilation (defined as self-harming acts not intended to kill that produced visible tissue damage requiring medical intervention) was found to be a negative predictor, a post-hoc analysis revealed that improvement rates in self-mutilating patients were significantly different in the two different treatment programs ( table 3 ) . Of the 20 patients allocated to the step-down program who had self-harmed in the year prior to being admitted, 12 (60%) were found to be improved, while only 5 (24%) of the 21 patients with self-harm included in the one-stage program improved; the difference was significant ( 2 = 5.53, d.f. = 1, p = 0.02) and the effect size between the two subgroups was of marked degree (Cohen's h = 0.75). The difference in improvement rates between non-self-harming patients in the two programs was not significant ( 2 = 1.52, d.f. = 1, p = 0.22) and Cohen's h showed an effect size of moderate magnitude (0.46).
Improvement, Diagnostic Clusters and Treatment Program
In order to address the question of the possible impact on outcome of specific Axis I (psychiatric syndromes) and Axis II (PD) diagnostic co-occurrences [17] , two separate cluster analytic procedures were carried out on the SCID-derived diagnosis found in our cluster B sample. As the next step, we tested the significance of the association between each of the two identified diagnostic clusters with improvement at 24-month follow-up using 2 test. The cluster analysis on Axis I diagnoses identified two centers: (1) a larger group whose primary Axis I diagnosis was major depression (n = 52), and (2) a smaller more heterogeneous group with anxiety or substance misuse diagnoses (substance abuse, obsessive-compulsive disorder, panic disorder, agoraphobic disorder and sociophobic disorder; n = 21). No association with improved status at 24 months ( 2 = 0.87, d.f. = 1, p = 0.35) was found, and a small effect size (Cohen's h = 0.24) was observed.
Two homogeneous clusters identifiable on the basis of comorbid PD diagnoses were found: (1) a large borderline and self-defeating group (B-SF; n = 44), and (2) a smaller borderline, avoidant, paranoid, dependent cluster (BAPD) (n = 29). A crosstabulation revealed that 30 (68%) patients in the B-SF cluster had achieved clinically significant improvement at 24-month follow-up, compared with only 11 (38%) in the BAPD cluster. The difference was significant ( 2 = 6.50, d.f. = 1, p = 0.01) and the effect size was moderate (Cohen's h = 0.61).
The difference in outcome between the two PD diagnostic clusters appears to be accounted for by a differential treatment response in program allocation, since there was no asymmetry in PD diagnostic prevalence in the step-down and inpatient treatment programs. Whereas almost 90% (n = 18) of B-SF patients allocated to the stepdown model improved, only 52% (n = 12; 2 = 5.69, d.f. = 1, p = 0.02; Cohen's h = 0.75) of those allocated to the inpatient program did so. There was no similar difference between the improvement rates in the two treatment arms for the BAPD cluster. The improvement rates were lower but comparable for the two treatment models (46 and 31%, respectively; 2 = 0.68, d.f. = 1, p = 0.4; Cohen's h = 0.31). Thus, it seems that therapeutic advantage came especially from the step-down treatment of the self-defeating borderline group of patients.
Discussion
Previous studies of prediction in PD were criticized because they were either insufficiently specific (their findings would apply to most psychiatric disorders) or yielded statistically significant results but of low clinical usefulness [18] . In this study, we found five significant predictors of medium-term outcome in a cluster B PD sample. Presence of self-harm, avoidant PD and age were found to be negative predictors of clinically significant improvement, while better global adjustment (GAS) and longer stay in treatment predicted positive outcome by 24-month follow-up. Although age and global functioning scores are likely to be nonspecific factors, treatment length, comorbid avoidant PD and self-harm affecting the chances of achieving positive outcome carry potential clinical implications concerning patient selection and treatment delivery for inpatient and outpatient psychosocial programs.
The finding that longer treatment predicted positive outcome points to the need for longer, open-ended psychological therapy and ongoing psychosocial support for patients with cluster B disorders, a group who suffer from a severe degree of psychosocial impairment. These patients are in need of long-term psychological treatment and ongoing support to maintain improvement made in the course of therapy and to enable them to compensate for deficits in social functioning.
Avoidant PD as negative predictor may be accounted for by their aversion of any intense emotions regardless of valence (positive or negative), of novel situations and risk taking, as well as withdrawals from social situations and intense feeling of inadequacy [19] . Consequently, these patients employ a range of avoidant strategies to protect them from the experience of the affective instability and psychic pain that engagement in a psychotherapeutic situation sometimes entails. The intensity of conditions within a therapeutic community setting with its emphasis on sharing, externalizing emotional states, and continuous enquiry about one's own functioning pose a serious challenge to avoidant patients. They may thus employ subtle defensive operations by seemingly complying with the milieu demands, becoming inconspicuous or taking on a pseudo-professional role by becoming competent and helpful to other patients in distress [20] .
The finding concerning self-harm as negative predictor seems to be related to a differential response between the two different treatment programs. The step-down program led to significant improvement within this selfharming sample. The low improvement found in the onestage program may point to the presence of iatrogenic factors present in long-term hospitalization, which undermine the positive and rehabilitative efforts present in the therapeutic community program. Recently, Fonagy and Bateman [4] argued that more positive outcomes for cluster B patients in the last two decades were most likely associated with the reduction in the offer of harmful interventions (such as long-term inpatient care) to this group rather than with the greater availability of evidence-based new treatment methods.
The step-down program also seems to be more successful in treating patients meeting criteria for borderline PD with self-defeating features than the one-stage model (86 vs. 52% improvement rate, respectively). Cluster B patients are individuals with very severe attachment problems who may react negatively to inpatient care [21, 22] . However, in our sample patients with self-defeating features responded positively to a phased program in which the overall treatment intensity is modulated, allowing for a more gradual process of individuation, meeting their needs for object constancy and enhancing the possibility of modifying a disorganized attachment to others. For the paranoid, avoidant type of cluster B patients improvement rates are relatively lower, and it is likely that patients in the BAPD cluster might present with relatively more intractable problems that are more enduring and harder to shift in treatment [23] . Thus, the impact of either psychosocial program is likely to be more limited than in B-SD patients.
The relatively low sample size for a regression analysis is a limitation to be borne in mind when considering the results of the study. It is possible that outliers in the covariates may have affected their significance as predictors in the logistic regression, and a larger sample of cluster B patients may be needed to ensure greater reliability of results.
